| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2025-04-09 |
$9.42 |
0.0% |
25,000
|
$235,500 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
Oruka Therapeutics, Inc. (ORKA)
|
2025-02-14 |
$11.45 |
0.0% |
122,882
|
$1,407,368 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2025-02-13 |
$9.27 |
0.0% |
161,700
|
$1,498,661 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2025-02-11 |
$9.26 |
0.0% |
104,489
|
$967,145 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2025-02-03 |
$8.88 |
0.0% |
70,023
|
$621,628 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2024-02-08 |
$14.62 |
-12.0% |
86,048
|
$1,257,829 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2024-01-30 |
$14.47 |
-11.1% |
88,099
|
$1,274,793 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2024-01-29 |
$14.05 |
-8.4% |
91,804
|
$1,289,802 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2024-01-24 |
$12.53 |
2.7% |
99,129
|
$1,241,685 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2024-01-19 |
$12.55 |
2.6% |
143,605
|
$1,801,602 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2024-01-16 |
$12.72 |
1.2% |
26,246
|
$333,779 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2024-01-10 |
$12.54 |
2.6% |
137,700
|
$1,726,457 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2024-01-04 |
$12.14 |
6.0% |
59,369
|
$720,543 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
KalVista Pharmaceuticals, Inc. (KALV)
|
2023-12-29 |
$12.46 |
3.3% |
519,017
|
$6,465,650 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
Altimmune, Inc. (ALT)
|
2020-06-15 |
$7.54 |
-15.3% |
1,500,000
|
$11,310,000 |
| Venrock Healthcare Capital Partners Iii, L.P. |
Non-Executive |
Altimmune, Inc. (ALT)
|
2020-05-28 |
$8.74 |
-26.9% |
1,303,636
|
$11,395,493 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-11.0% |
$-4,801,809 |
$43,547,934 |